Corporate Banner
Satellite Banner
Biomolecular Screening
Scientific Community
 
Become a Member | Sign in
Home>Products>This Product
  Products


LUMIstar OPTIMA Microplate Luminometer

Product Description
lumistar-optima.jpg

The LUMIstar OPTIMA is a luminescence microplate reader that is designed for the widest possible range of applications based on luminescence modes of detection:

• Reporter gene assays luciferase, e.g. ß-galactosidase, gene activities with luminescence substrates (luminol, acridinium esters, dioxetanes.)
• Cell-based assays , e.g. cytotoxicity and proliferation, intracellular Ca2+ with aequorin
• Dual Luciferase
• Renilla, Gaussia, Firefly, Cypridina
• ATP assays
• Luminescent immunoassays
• GUS assays (ß-glucuronidase)
• ROS (reactive oxygen species)
• Enzyme activity assays
• Nucleic acid detection (PCR Quantification)
• ADP-GloTM
• Multi-tox Glo

BMG LABTECH's Digital Photon Integration (DPI) technology and programmable gain control give the LUMIstar OPTIMA the best sensitivity, with an extended linear dynamic range. By incorporating on-board reagent injectors that measure at the point of injection, flash kinetic reactions can be measured in as little as 20 microsecond steps. The faster transport system allows 96-well plates to be read in as little as 50 measurements per second.

Additional outstanding features:
The LUMIstar OPTIMA comes with incubation, including temperature-regulated heating plates above and below the entire plate movement area to provide uniform incubation up to 45°C or even up to 60°C. A gas vent connection can be added, offering a tremendous advantage for assays where special or inert gas is needed when working with atmospheric gas sensitive samples. Up to two on-board reagent injectors can be added, both simultaneously accessing the measurement position and providing unlimited possibilities for fast kinetic assays. The automatic gain calculation provides the optimum dynamic range for each assay.

Upgradeable to FLUOstar OPTIMA or POLARstar OPTIMA
Due to the modular concept of the LUMIstar OPTIMA, whenever the need for fluorescence or absorbance based experiments arrive, the LUMIstar OPTIMA can be upgraded to a FLUOstar OPTIMA. It can also be upgraded to a POLARstar OPTIMA to include fluorescence polarization and Simultaneous Dual Emission Detection.

Control and MARS Data Evaluation Software
For first time users, the LUMIstar OPTIMA Control Software offers an easy to use Quick start feature. But for advanced users, it offers flexible definition of microplate layouts, filter selection, interval and injection times, measurement and shaking parameters. During the measurement, it is possible to observe the data with the Real Time Graphics feature. While the Standard Curve Wizard creates an easy step-by-step calculation of a standard curve and the Template Manager is an excellent tool for building complex data processing protocols. With MARS, all data analysis is simply done with one click of the mouse.
Product LUMIstar OPTIMA Microplate Luminometer
Company BMG Labtech GmbH
Price Request a quote
More Information View company product page
Catalog Number Unspecified
Quantity Unspecified
Company Logo

BMG Labtech GmbH
Allmendgruen 8, 77799 Ortenberg Germany

Tel: +49 781 96968-0
Fax: +49 781 96968-67
Email: hts@bmglabtech.com



Scientific News
Platelets are the Pathfinders for Leukocyte Extravasation During Inflammation
Findings from the study could help in the prevention and treatment of inflammatory pathologies.
Benchtop Automation Trends
Gain a better understanding of current interest in and future deployment of benchtop automated systems.
Penn State, TB Alliance, and GSK Partner To Discover New Treatments For TB
A new collaboration between TB Alliance, GSK, and scientists in the Eberly College of Science seeks to find new small molecules that can be used to create antibiotics in the fight against tuberculosis (TB).
Molecular Map Provides Clues To Zinc-Related Diseases
Mapping the molecular structure where medicine goes to work is a crucial step toward drug discovery against deadly diseases.
Genetic Research Can Significantly Improve Drug Development
With drug development costs topping $1.2bn (£850 million) to get a single treatment to the point it can be sold and used in the clinic, could genetic analysis save hundreds of millions of dollars?
New Method Opens Door to Development of Many New Medicines
Findings from TSRI reveal human proteins are better drug targets than previously thought.
Diagnosing Systemic Infections Quickly, Reliably
Team develop rapid and specific diagnostic assay that could help physicians decide within an hour whether a patient has a systemic infection and should be hospitalized for aggressive intervention therapy.
What Makes a Good Scientist?
It’s the journey, not just the destination that counts as a scientist when conducting research.
Blood Test That Detects Early Alzheimer’s Disease
A research team, led by Dr. Robert Nagele from Rowan University School of Osteopathic Medicine and Durin Technologies, Inc., has announced the development of a blood test that leverages the body’s immune response system to detect an early stage of Alzheimer’s disease – referred to as the mild cognitive impairment (MCI) stage – with unparalleled accuracy.
A New Approach to Chemical Synthesis
Communesins, originally found in fungus, could hold potential as cancer drugs.

SELECTBIO

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,200+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,700+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!